ISIS 104838

DB16201InvestigationalGene Therapies

ISIS 104838 is under investigation in clinical trial NCT00048321 (ISIS 104838, an Inhibitor of Tumor Necrosis Factor, for Active Rheumatoid Arthritis).

Mechanism: Pharmacologically active on Tumor necrosis factor
Curator reviewed
Code names: ISIS-104838

Resolves to

Compound

UNII8BLG99WDHSCAS250755-32-9

Targets

P01375TNF

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with ISIS 104838, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account